Available Clinical Trials

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355). E-mail: askroswell@roswellpark.org
 

Asciminib as Initial Therapy with Addition of Lower Dose Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia who do not Achieve Optimal Response or a Deep Molecular Remission (ALERT CML)

Principal Investigator: Thompson, J

A Comprehensive Education and Navigational Support Program for Advanced Bladder Cancer

Principal Investigator: George, Saby

Symptom Management in the Hematopoietic Stem Cell Transplantation Patient Population Using Virtual Reality

Principal Investigator: Huizinga, Heather E

A032102: PRECISION DIAGNOSTICS IN PROSTATE CANCER TREATMENT (PREDICT)

Principal Investigator: Chatta, Gurkamal S

A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR)-altered, Chemotherapy- and FGFR Inhibitor…

Principal Investigator: Fountzilas, Christos

A Phase I/II Study of Interstitial Photodynamic Therapy Following Palliative Radiotherapy for Patients with Inoperable Malignant Central Airway Obstruction

Principal Investigator: Ivanick, Nathaniel M

A Pragmatic Phase II Trial of Chemotherapy +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers

Principal Investigator: Kabraji, Sheheryar K

Respiratory Muscle Training During Breast Cancer Treatment: Effects on the Autonomic Nervous System and Cardiotoxicity

Principal Investigator: Levine, Ellis G

A Phase IIa Study of Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab in Patients with Asymptomatic Brain Metastasis from Triple Negative Breast Cancer (TNBC) or HER2+ Breast Cancer (HER2+BC) or Hormone Receptor Positive (HR+) Breast Cancer.

Principal Investigator: Kabraji, Sheheryar K

A PHASE 1/2 STUDY OF LINVOSELTAMAB IN PATIENTS WITH RELAPSED OR REFRACTORY SYSTEMIC LIGHT CHAIN AMYLOIDOSIS

Principal Investigator: Hassan, Hamza

An Open-label, Multicenter Study of ZL-1310 to Evaluate the Safety, Tolerability, and Pharmacokinetics in Subjects with Small Cell Lung Cancer

Principal Investigator: Dy, Grace K

Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients with Loco-regionally Advanced or Recurrent Colorectal Cancer Undergoing Surgery; Phase I/II

Principal Investigator: Dakwar, Anthony

Phase 1, Open-Label, Multi-Center, Dose Escalation and Expansion Study Evaluating the Safety, Tolerability and Clinical Activity of Decoy20 in Patients with Advanced Solid Tumors

Principal Investigator: Krishnamurthy, Anuradha

Thriving Beyond Breast Cancer: Post-Treatment Supportive Services Programming for Black Women to Alleviate Disparities During Survivorship

Principal Investigator: Devonish, Julia A

A Randomized Double Blinded Trial of Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.

Principal Investigator: Holtan, Shernan G

Expanded Access to SurVaxM for Treatment of Patients with Glioblastoma Who Have No Access to Other Comparable or Alternative Therapy or Have Completed Treatment on a non-Randomized Clinical Trial of SurVaxM and May Benefit from Further Treatment

Principal Investigator: Abad, Ajay P

Sensory Evaluation of Cigarettes Claiming Removal of Menthol as a Characterizing Flavor

Principal Investigator: O'Connor, Richard J

Phase 1 Trial of SX-682, a CXCR 1/2 Inhibitor, in Combination with Standard of Care Treatment in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

Principal Investigator: Hillengass, Jens

AFT-65/ASCENT-05 OptimICE-RD: A Randomized, Open-label, Phase 3 Study of Adjuvant Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After…

Principal Investigator: Levine, Ellis G

Randomized Study of ONC-392 plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) who Progressed on Androgen Receptor (AR) Pathway Inhibition

Principal Investigator: Chatta, Gurkamal S

(ID-COMET) A Randomized Phase III Trial of Immediate Versus Six-Month Delayed Comprehensive Treatment of 1-10 Oligometastatic Tumors With or Without Synchronous Primary

Principal Investigator: Singh, Anurag K

Feasibility of a Community-Based Cancer Survivor Exercise and Nutrition Education Program: Effects on Self Efficacy, Quality of Life and Functional Performance

Principal Investigator: Ray, Andrew D

A Phase 1, Open-Label, Dose Escalation and Expansion Study of ASP1012, an Oncolytic Virus, in Participants with Locally Advanced or Metastatic Solid Tumors ( 1012-CL-0101)

Principal Investigator: Switzer, Benjamin J

A Phase II Study of CPX-351 in Younger Patients < 60 Years Old with Secondary Acute Myeloid Leukemia

Principal Investigator: Green, Steven D

(AHOD2131) A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

Principal Investigator: Kelly, Kara M